APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Tadeusz Robak

Get full text

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Tadeusz Robak

Get full text

Editorial: Novel targeted drugs for indolent lymphoid malignancies by Tadeusz Robak, Tadeusz Robak, Bartosz Puła, Iwona Hus

Get full text

Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance by Tadeusz Robak, Tadeusz Robak, Paweł Robak, Paweł Robak

Get full text

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions by Anna Wolska-Washer, Anna Wolska-Washer, Tadeusz Robak, Tadeusz Robak

Get full text

Chronic lymphocytic leukemia by Tadeusz Robak, (Coordinating Author)

Get full text

Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later by Pawel Robak, Tadeusz Robak

Get full text

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment by Halina Urbanska-Rys, Tadeusz Robak

Get full text

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus by Ewa Robak, Anna Sysa-jedrzejewska, Tadeusz Robak

Get full text

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia by Joanna Gora-Tybor, Jerzy Z. Blonski, Tadeusz Robak

Get full text

Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases by Pawel Robak, Ewa Lech-Maranda, Tadeusz Robak, Anna Korycka

Get full text

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia by Magdalena Witkowska, Agata Majchrzak, Barbara Cebula-Obrzut, Ewa Wawrzyniak, Tadeusz Robak, Piotr Smolewski

Get full text

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus by Ewa Robak, Agnieszka Wierzbowska, Magdalena Chmiela, Liliana Kulczycka, Anna Sysa-Jedrejowska, Tadeusz Robak

Get full text

Przebieg ciąży i porodu u pacjentki z ostrą białaczką szpikową. Opis przypadku by Michał Krekora, Lidia Biesiada, Anna Kędzierska, Agnieszka Pluta, Piotr Krajewski, Tadeusz Robak, Grzegorz Krasomski

Get full text

Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia by Ewa Lech-Maranda, Przemyslaw Juszczynski, Anna Szmigielska-Kaplon, Krzysztof Jamroziak, Ewa Balcerczak, Tadeusz Robak

Get full text

Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus by Agnieszka Klonowska-Szymczyk, Anna Wolska, Tadeusz Robak, Barbara Cebula-Obrzut, Piotr Smolewski, Ewa Robak

Get full text

Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus by Ewa Robak, Jerzy Z. Błoński, Jacek Bartkowiak, Hanna Niewiadomska, Anna Sysa-Jędrzejowska, Tadeusz Robak

Get full text

Lymphocytes Tγδ in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity by Ewa Robak, Hanna Niewiadomska, Tadeusz Robak, Jacek Bartkowiak, Jerzy Z. Blonski, Anna Wozniacka, Lech Pomorski, Anna Sysa-Jedrzejowska

Get full text

Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial by Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chuan Wun, Wojciech Jurczak, Stephen D. Smith

Get full text

P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT-NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL by Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chaun Wun, Wojciech Jurczak, Stephen D. Smith

Get full text